Search results
Results From The WOW.Com Content Network
Transmasculine people may pursue chest reconstruction, also known as top surgery, as part of transitioning. The removal of breast tissue in male chest reconstruction is a type of mastectomy called a subcutaneous (under the skin) mastectomy. This type of mastectomy removes tissue from inside the breast (subcutaneous tissue), as well as excess ...
During the 20-year study period, 8.5 percent of women who had lumpectomies died from breast cancer, nine percent of women who had mastectomies died from the disease, and 8.5 percent of women who ...
Top surgery involves more than a mastectomy for the treatment of breast cancer. [1] Special techniques are used to contour and reduce the chest wall, position the nipples and areola, and minimize scarring. [1] If the breast size is small, surgery that spares the skin, nipple and areola (subcutaneous nipple-sparing mastectomy) may be performed ...
Male breast cancer (MBC) is a cancer in males that originates in their breasts. Males account for less than 1% of new breast cancers with about 20,000 new cases being diagnosed worldwide every year. [ 1][ 2] Its incidence rates in males vs. females are, respectively, 0.4 and 66.7 per 100,000 person-years (person-years is the number of new cases ...
Since 2017, hundreds of females age 12-1/2 and younger with gender dysmorphia have had double mastectomies, according to analysis by the Manhattan Institute. Doctors expressed concern.
v. t. e. Masculinizing hormone therapy, also known as transmasculine hormone therapy or female-to-male (or FTM) hormone therapy, is a form of hormone therapy and gender affirming therapy which is used to change the secondary sexual characteristics of transgender people from feminine or androgynous to masculine. [ 1][ 2][ 3] It is a common type ...
Gender-affirming surgery is a surgical procedure, or series of procedures, that alters a person's physical appearance and sexual characteristics to resemble those associated with their identified gender. The phrase is most often associated with transgender health care and intersex medical interventions, although many such treatments are also ...
[155]: 199–200 By 2010 the breast cancer survival rate in Europe was 91% at one years and 65% at five years. In the USA the five-year survival rate for localized breast cancer was 96.8%, while in cases of metastases it was only 20.6%. Because the prognosis for breast cancer was at this stage relatively favorable, compared to the prognosis for ...